PL429790A1 - New terpenoid derivative and its application in chemoprevention and cancer chemotherapy support - Google Patents

New terpenoid derivative and its application in chemoprevention and cancer chemotherapy support

Info

Publication number
PL429790A1
PL429790A1 PL429790A PL42979019A PL429790A1 PL 429790 A1 PL429790 A1 PL 429790A1 PL 429790 A PL429790 A PL 429790A PL 42979019 A PL42979019 A PL 42979019A PL 429790 A1 PL429790 A1 PL 429790A1
Authority
PL
Poland
Prior art keywords
application
chemoprevention
cancer chemotherapy
terpenoid derivative
chemotherapy support
Prior art date
Application number
PL429790A
Other languages
Polish (pl)
Other versions
PL240449B1 (en
Inventor
Agata Kozioł
Kamila Środa-Pomianek
Anna Palko-Łabuz
Krystyna MICHALAK
Mirosława FERENS-SIECZKOWSKA
Original Assignee
Uniwersytet Medyczny Im. Piastów Śląskich We Wrocławiu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Medyczny Im. Piastów Śląskich We Wrocławiu filed Critical Uniwersytet Medyczny Im. Piastów Śląskich We Wrocławiu
Priority to PL429790A priority Critical patent/PL240449B1/en
Priority to PCT/PL2020/050035 priority patent/WO2020226520A1/en
Publication of PL429790A1 publication Critical patent/PL429790A1/en
Publication of PL240449B1 publication Critical patent/PL240449B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/608—Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a ring other than a six-membered aromatic ring in the acid moiety
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Przedmiotem zgłoszenia jest nowa pochodna terpenoidowa o wzorze 1. Przedmiotem zgłoszenia jest także zastosowanie związku o wzorze 1 jako lek w chemoprewencji i wspomaganiu chemioterapii nowotworów, zwłaszcza nowotworu jelita grubego. Zgłoszenie obejmuje także kompozycję farmaceutyczną, zawierającą związek o wzorze 1 i farmaceutycznie dopuszczalny nośnik lub zaróbkę.The subject of the application is a new terpenoid derivative of the formula 1. The subject of the application is also the use of a compound of the formula 1 as a drug in the chemoprevention and chemotherapy support of neoplasms, especially colorectal neoplasm. The application also includes a pharmaceutical composition comprising a compound of Formula 1 and a pharmaceutically acceptable carrier or excipient.

PL429790A 2019-05-06 2019-05-06 New terpenoid derivative and its application in chemoprevention and cancer chemotherapy support PL240449B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PL429790A PL240449B1 (en) 2019-05-06 2019-05-06 New terpenoid derivative and its application in chemoprevention and cancer chemotherapy support
PCT/PL2020/050035 WO2020226520A1 (en) 2019-05-06 2020-05-06 A new terpenoid derivative and its use in chemoprevention and supporting cancer chemotherapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL429790A PL240449B1 (en) 2019-05-06 2019-05-06 New terpenoid derivative and its application in chemoprevention and cancer chemotherapy support

Publications (2)

Publication Number Publication Date
PL429790A1 true PL429790A1 (en) 2020-11-16
PL240449B1 PL240449B1 (en) 2022-04-04

Family

ID=73050628

Family Applications (1)

Application Number Title Priority Date Filing Date
PL429790A PL240449B1 (en) 2019-05-06 2019-05-06 New terpenoid derivative and its application in chemoprevention and cancer chemotherapy support

Country Status (2)

Country Link
PL (1) PL240449B1 (en)
WO (1) WO2020226520A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007098118A2 (en) * 2006-02-16 2007-08-30 Byron Robinson Pharmaceutical, Inc. Antineoplastic and curcumin derivatives and methods of preparation and use
JP5442595B2 (en) * 2007-03-30 2014-03-12 ジボダン エス エー Functional organic compounds that block off notes

Also Published As

Publication number Publication date
PL240449B1 (en) 2022-04-04
WO2020226520A1 (en) 2020-11-12

Similar Documents

Publication Publication Date Title
CL2018002410A1 (en) Mcl-1 inhibitors and methods of use thereof
PH12020551305A1 (en) Pharmaceutical Compounds
CO2020000145A2 (en) Carboxamides as sodium channel modulators
CL2019001077A1 (en) 6,7,8,9-tetrahydro-3h-pyrazolo [4,3-f] isoquinoline derivatives useful in the treatment of cancer.
MY196173A (en) Cot Modulators And Methods Of Use Thereof
BR112016000489A8 (en) compound, pharmaceutical composition comprising it, use of the composition and methods for making compounds
MX2015012432A (en) Pyridine cdk9 kinase inhibitors.
UY30912A1 (en) DERIVATIVES OF 4-PIRAZOL AMIDAS CONTAINING CARBOXI, PHARMACEUTICALLY ACCEPTABLE SALTS OF THE SAME, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, PREPARATION AND USE PROCESSES.
MX2021003655A (en) Indole macrocyclic derivative, preparation method therefor and application thereof in medicine.
GEP20156289B (en) New aminopyrazoloquinazolines
EA201000091A1 (en) DERIVATIVES OF MORFOLINOPYRIMIDINE USED IN DISEASES ASSOCIATED WITH mTOR KINASE AND / OR PI3K
CL2021000175A1 (en) Pyrimidine Compounds and Pharmaceutical Compositions for Preventing or Treating Cancers Including The Same
ECSP19051352A (en) JAK1 SELECTIVE INHIBITORS
WO2017128917A8 (en) Parazole condensed-ring derivatives and preparation method thereof and application thereof in treatment of cancers, inflammation and immune diseases
MY179605A (en) Use of benzimidazole-proline derivatives
WO2015070238A3 (en) Coumarin based hsp90 inhibitors with urea and ether substituents
PH12020550815A1 (en) Delayed release deferiprone tablets and methods of using the same
MX2022008478A (en) Low-dose brimonidine combinations and uses thereof.
PH12021551057A1 (en) Macrocyclic tyrosine kinase inhibitor and uses thereof
PL426879A1 (en) Combination of isothiocyanates with organic selen compounds in drug carriers as a new pharmaceutical with antitumor activity
PL429790A1 (en) New terpenoid derivative and its application in chemoprevention and cancer chemotherapy support
MX2021014830A (en) CONJUGATES OF <i>π</i>-ELECTRON-PAIR-DONATING HETEROAROMATIC NITROGEN-COMPRISING COMPOUNDS.
PL427216A1 (en) Pharmaceutical formulation containing selenitetrigliceride and cytostatic for use in cancer treatment
AR121477A1 (en) COMPOUNDS AND METHODS FOR THE TREATMENT OF FUNGAL INFECTIONS
PL419082A1 (en) Xanthohumol for use in treatment or preventing haemorrhoidal diseases and the xanthohumol-containing composition